Yajie Zhu
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The claudin-18.2-CD3 bispecific antibody IBI389 exerts an antitumor effect on malignant tumors with positive claudin-18.2 expression by promoting T-cell infiltration and remodeling the tumor immune microenvironment.
Journal: Translational cancer research
Published: March 04, 2026
Long non-coding RNA LINRIS is upregulated in non-small cell lung cancer and its silencing inhibits cell proliferation by suppressing microRNA-10a maturation.
Journal: Bioengineered
Published: February 09, 2022
Not all bad: Drug-induced interstitial pneumonia in DLBCL patients is potentially fatal but could be linked to better survival.
Journal: Leukemia research
Published: May 19, 2021
Durable Response to Osimertinib in a Chinese Patient with Metastatic Lung Adenocarcinoma Harboring a Rare EGFR L858R/D761Y Compound Mutation.
Journal: OncoTargets and therapy
Published: June 20, 2020
MicroRNA-134 targets KRAS to suppress breast cancer cell proliferation, migration and invasion.
Journal: Oncology letters
Published: July 19, 2015
The Rho GTPase RhoE is a p53-regulated candidate tumor suppressor in cancer cells.
Journal: International journal of oncology
Published: November 01, 2013
KIAA0101 mRNA overexpression in peripheral blood mononuclear cells acts as predictive marker for hepatic cancer.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: September 29, 2013
Anti-tumor effects of atractylenolide I isolated from Atractylodes macrocephala in human lung carcinoma cell lines.
Journal: Molecules (Basel, Switzerland)
Published: September 02, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026